Advanced search
Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 17
Submit an article Journal homepage
164
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Two new organic acids from Portulaca oleracea L. and their anti-inflammatory and anticholinesterase activities

Peishan Liua School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, ChinaView further author information
,
Lingling Wanga School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, China;c School of Traditional Chinese Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang, ChinaView further author information
,
Huanfeng Lib Modern Rehabilitation Center, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, ChinaView further author information
,
Lishuang Tanb Modern Rehabilitation Center, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, ChinaCorrespondence[email protected] [email protected]
View further author information
,
Xixiang Yinga School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, ChinaCorrespondence[email protected] [email protected]
View further author information
&
Baozhao Juc School of Traditional Chinese Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang, ChinaView further author information
Pages 4395-4403 | Received 01 Jul 2021, Accepted 20 Oct 2021, Published online: 08 Nov 2021

References

  • Atri A. 2019. Current and future treatments in Alzheimer's disease. Semin Neurol. 39(2):227–240.
  • Azuka OI, Am B, Abu OL. 2014. A review on Portulaca oleracea (Purslane) plant – Its nature and biomedical benefits. Int J Biomed Res. 05
  • Blennow K, de Leon MJ, Zetterberg H. 2006. Alzheimer's disease. The Lancet. 368(9533):387–403.
  • Duan Y, Ying ZM, Zhang MB, Ying XX, Yang GL. 2020. Two new homoisoflavones from Portulaca oleracea L. and their activities. Nat Prod Res. 3:1–9.
  • Ellman GL, Courtney KD, Res V, JR, Featherstone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7(2):88–95.
  • Fujiwara M, Yagi N, Miyazawa M. 2010. Acetylcholinesterase inhibitory activity of volatile oil from Peltophorum dasyrachis Kurz ex Bakar (yellow batai) and Bisabolane-type sesquiterpenoids. J Agric Food Chem. 58(5):2824–2829.
  • Gu YY, Leng AJ, Zhang WJ, Ying XX, Stien D. 2020. A novel alkaloid from Portulaca oleracea L. and its anti-inflammatory activity. Nat Prod Res. 21:1–6.
  • Guo SN, Tao XJ, Duan Y, Cui XY, Zhang WJ, Li HB, Ying XX. 2020. A new naphthoic acid from Portulaca oleracea L. and its Activities. Lat Am J Pharm. 39:1575–1578.
  • Ittner LM, Gotz J. 2011. Amyloid-β and tau-a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci. 12(2):65–72.
  • Karimi G, Hosseinzadeh H, Ettehad N. 2004. Evaluation of the gastric antiulcerogenic effects of Portulaca oleracea L. extracts in mice. Phytother Res. 18(6):484–487.
  • Lei X, Li JM, Liu B, Zhang N, Liu HY. 2015. Separation and Identification of Four New Compounds with Antibacterial Activity from Portulaca oleracea L. Molecules. 20(9):16375–16387.
  • Li FL, Li QW, Gao DW, Peng Y, Feng CN. 2009. Preparation and antidiabetic activity of polysaccharide from Portulaca oleracea L. Afr J Biotechnol. 8:569–573.
  • Li YP, Yao LH, Wu GJ, Pi XF, Gong YC, Ye RS, Wang CX. 2014. Antioxidant activities of novel small-molecule polysaccharide fractions purified from Portulaca oleracea L. Food Sci Biotechnol. 23(6):2045–2052.
  • Ma YF, Bao YR, Zhang WJ, Ying XX, Stien D. 2020. Four lignans from Portulaca oleracea L. and its antioxidant activities. Nat Prod Res. 34(16):2276–2282.
  • Ma YF, Li XT, Zhang WJ, Ying XX, Stien D. 2021. A trace alkaloid, oleraisoindole A from Portulaca oleracea L. and its anticholinesterase effect. Nat Prod Res. 35(2):350–353.
  • Meng YH, Ying ZM, Xiang Z, Hao D, Zhang WJ, Zheng Y, Gao YC, Ying XX. 2016. The anti-inflammation and pharmacokinetics of a novel alkaloid from Portulaca oleracea L. J Pharm Pharmacol. 68(3):397–405.
  • Oh JH, Seo Y, Kong CS. 2019. Anti-photoaging effects of solvent-partitioned fractions from Portulaca oleracea L. on UVB-stressed human keratinocytes. J Food Biochem. 43(4):e12814.
  • Pakaski M, Kalman J. 2008. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease. Neurochem Int. 53(5):103–111.
  • Saresella M,La Rosa F,Piancone F,Zoppis M,Marventano I,Calabrese E,Rainone V,Nemni R,Mancuso R,Clerici M. 2016. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease. Mol Neurodegener. 11:23 doi:10.1186/s13024-016-0088-1. PMC: 26939933
  • The Pharmacopoeia Commission of PRC. 2020. The pharmacopoeia of the People’s Republic of China (Part 1). Beijing: China Medical Science and Technology Press; p. 51–52.
  • Wang HQ, Zhang LY, Wang YY. 2017. Isolating and identifying organic acids from Portulaca oleracea and determining their anti-cyanobacterial activity. Pol J Environ Stud. 26(1):441–445.
  • Xin HL, Xu YF, Hou YH, Zhang YN, Yue XQ, Lu JC, Ling CQ. 2008. Two novel triterpenoids from Portulaca oleracea L. Helv Chim Acta . 91(11):2075–2080.
  • Xiu F, Li XT, Zhang WJ, He F, Ying XX, Stien D. 2019. A new alkaloid from Portulaca oleracea L. and its antiacetylcholinesterase activity. Nat Prod Res. 33(18):2583–2590.
  • Yang X, Ying ZM, Liu HR, Ying XX, Yang GL. 2019. A new homoisoflavone from Portulaca oleracea L. and its antioxidant activity. Nat Prod Res. 33(24):3500–3506.
  • Yang X, Zhang WJ, Ying XX, Stien D. 2018. New flavonoids from Portulaca oleracea L. and their activities. Fitoterapia. 127:257–262.
  • Zhao CC, Zhang CG, He F, Zhang WJ, Leng AJ, Ying XX. 2019. Two new alkaloids from Portulaca oleracea L. and their bioactivities. Fitoterapia. 136:104166.
  • Zhao R, Zhang T, Ma BL, Li X. 2017. Antitumor activity of Portulaca oleracea L. polysaccharide on HeLa cells through inducing TLR4/NF-κB signaling. Nutr Cancer. 69(1):131–139.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.